Skip to product information
1 of 1

ZSCAN4 Recombinant Rabbit mAb (S-4778-76)

ZSCAN4 Recombinant Rabbit mAb (S-4778-76)

Catalog Number: S0B60832 Application: WB Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen ZSCAN4
Immunogen Synthetic Peptide
Location Nucleus
Accession Q8NAM6
Clone Number S-4778-76
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Hu
Purification Immunogen Affinity
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu

Background

ZSCAN4 (zinc finger and SCAN domain-containing protein 4) is a transcription factor that plays key regulatory roles in embryonic stem cells and cancer cells and belongs to the protein family containing a SCAN box and C2H2-type zinc fingers. Structurally, it contains an N-terminal SCAN domain and multiple C-terminal C2H2 zinc-finger motifs, enabling sequence-specific DNA binding. Functionally, ZSCAN4 is specifically expressed in mouse embryonic stem cells and maintains telomere length and genomic stability by binding telomeres and promoting telomere sister chromatid exchange, thereby resisting cellular senescence and supporting the maintenance of pluripotency. Recent studies have further revealed that ZSCAN4 also plays important roles in tumors: in head and neck squamous cell carcinoma, ZSCAN4 is enriched in the cancer stem cell population and, by promoting histone H3 hyperacetylation, upregulates core pluripotency factors such as OCT3/4 and NANOG as well as cancer stem cell markers, thereby maintaining the self-renewal capacity of cancer stem cells; knockdown of ZSCAN4 significantly inhibits tumor sphere formation and tumor growth in vivo. In addition, ZSCAN4 participates in maintaining centromere integrity during oocyte meiosis, and its loss leads to reduced centromeric proteins such as CENP-A and abnormal chromosome alignment. In terms of clinical relevance, low ZSCAN4 expression in urothelial carcinoma is significantly associated with advanced pathological stage, lymph node metastasis, and poor prognosis, suggesting that it may serve as an independent prognostic marker.

Picture

Western Blot

WB result of ZSCAN4 Recombinant Rabbit mAb
Primary antibody: ZSCAN4 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated 293F whole cell lysate 20 µg
Lane 2: 293F transfected with ZSCAN4-myc-His fusion protein whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 49 kDa
Observed MW: 56 kDa